With patient safety becoming more critical than ever in today's evolving healthcare landscape, the demand for robust drug safety practices continues to surge.
Ichnos Glenmark Innovation (IGI), a global, fully integrated clinical- stage biotechnology company focused on developing multispecificsTM in oncology, today presented promising full dose-escalation results from its Phase 1 TRIgnite-1 study of ISB 2001
Biocon Pharma Limited, has received approval for its Liraglutide drug product (6 mg/ml solution for injection in pre-filled pen and cartridge), from the Drugs Controller General of India, CDSCO (Central Drugs Standard Control Organisation).
Posses a degree in pharmacy or a diploma in pharmacy of a recognized university or a equivalent educational qualification and must have registered his, her name with the Gujarat pharmacy council.
M.Sc in Pharmaceutical Sciences or M.Pharm; M.Sc in Biochemistry / Moloecular Biology / Biotechnology; NIIST is a constituent Laboratory of the Council of Scientific and Industrial Research
Master, Integrated Masters in Natural or Agricultural or Pharmaceutical Sciences, MVSc, Animal Sciences OR Bachelors degree in Engineering or Technology or Medicine from a recognized University.